Published in J Diabetes Sci Technol on November 01, 2009
Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. BMJ (2007) 11.09
Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review. Diabetes Care (2005) 8.94
Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study. Diabetologia (2005) 5.47
Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial. BMJ (2008) 5.29
The effect of self monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: a blinded, randomized trial. Am J Med (2005) 4.15
Meal-related structured self-monitoring of blood glucose: effect on diabetes control in non-insulin-treated type 2 diabetic patients. Diabetes Care (2002) 2.96
Self-monitoring of blood glucose as part of a multi-component therapy among non-insulin requiring type 2 diabetes patients: a meta-analysis (1966-2004). Curr Med Res Opin (2005) 2.81
Longitudinal study of new and prevalent use of self-monitoring of blood glucose. Diabetes Care (2006) 2.44
The efficacy of self-monitoring of blood glucose in the management of patients with type 2 diabetes treated with a gliclazide modified release-based regimen. A multicentre, randomized, parallel-group, 6-month evaluation (DINAMIC 1 study). Diabetes Obes Metab (2008) 1.59
Self-monitoring of blood glucose in type 2 diabetes: a new look at published trials. Diabetologia (2008) 1.45
Self-monitoring of glucose in type 2 diabetes mellitus: a Bayesian meta-analysis of direct and indirect comparisons. Curr Med Res Opin (2006) 1.45
Does patient blood glucose monitoring improve diabetes control? A systematic review of the literature. Diabetes Educ (2007) 1.36
Effect of the frequency of self-monitoring blood glucose in patients with type 2 diabetes treated with oral antidiabetic drugs-a multi-centre, randomized controlled trial. PLoS One (2008) 1.21
Self-monitoring of blood glucose levels in patients with type 2 diabetes mellitus not taking insulin: a meta-analysis. Am J Manag Care (2008) 1.19
Does self-monitoring of blood glucose improve outcome in type 2 diabetes? The Fremantle Diabetes Study. Diabetologia (2007) 1.16
New evidence demonstrates that self-monitoring of blood glucose does not improve outcomes in type 2 diabetes-when this practice is not applied properly. J Diabetes Sci Technol (2008) 1.15
The value of self-monitoring of blood glucose: a review of recent evidence. J Diabetes Complications (2009) 1.07
Altered disease course after initiation of self-monitoring of blood glucose in noninsulin-treated type 2 diabetes (ROSSO 3). J Diabetes Sci Technol (2007) 1.00
Interrelations between diabetes therapy, self-monitoring of blood glucose, blood glucose and non-fatal or fatal endpoints in patients with type 2 diabetes / results of a longitudinal cohort study (ROSSO 5). Arzneimittelforschung (2007) 0.82
Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes. Diabetes (2004) 3.66
Comparison of the numerical and clinical accuracy of four continuous glucose monitors. Diabetes Care (2008) 3.66
Elevated levels of interleukin-18 predict the development of type 2 diabetes: results from the MONICA/KORA Augsburg Study, 1984-2002. Diabetes (2005) 1.98
Accuracy and reliability of continuous glucose monitoring systems: a head-to-head comparison. Diabetes Technol Ther (2013) 1.71
Effects of coffee consumption on subclinical inflammation and other risk factors for type 2 diabetes: a clinical trial. Am J Clin Nutr (2010) 1.58
Technical evaluation of the first fully automated assay for the detection of TSH receptor autoantibodies. Clin Chim Acta (2008) 1.56
ROSSO-in-praxi: a self-monitoring of blood glucose-structured 12-week lifestyle intervention significantly improves glucometabolic control of patients with type 2 diabetes mellitus. Diabetes Technol Ther (2010) 1.56
Blood glucose meter market: this world is undergoing drastic changes. J Diabetes Sci Technol (2013) 1.51
Consensus report: the current role of self-monitoring of blood glucose in non-insulin-treated type 2 diabetes. J Diabetes Sci Technol (2011) 1.50
Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: Action LADA 7. Diabetes Care (2012) 1.49
Increased concentrations of C-reactive protein and IL-6 but not IL-18 are independently associated with incident coronary events in middle-aged men and women: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Arterioscler Thromb Vasc Biol (2006) 1.46
Basal-prandial insulin delivery in type 2 diabetes mellitus via the V-Go: a novel continuous subcutaneous infusion device. J Diabetes Sci Technol (2008) 1.46
A randomised, controlled trial of self-monitoring of blood glucose in patients with type 2 diabetes receiving conventional insulin treatment. Diabetologia (2014) 1.38
Real-time improvement of continuous glucose monitoring accuracy: the smart sensor concept. Diabetes Care (2012) 1.37
Continuous glucose monitoring accuracy results vary between assessment at home and assessment at the clinical research center. J Diabetes Sci Technol (2012) 1.35
Low-grade inflammation, obesity, and insulin resistance in adolescents. J Clin Endocrinol Metab (2007) 1.32
Day and night closed-loop control in adults with type 1 diabetes: a comparison of two closed-loop algorithms driving continuous subcutaneous insulin infusion versus patient self-management. Diabetes Care (2013) 1.32
Performance of screening questionnaires and risk scores for undiagnosed diabetes: the KORA Survey 2000. Arch Intern Med (2005) 1.28
Continuous glucose monitoring with glucose sensors: calibration and assessment criteria. Diabetes Technol Ther (2003) 1.24
Corticotropin-releasing hormone: an autocrine hormone that promotes lipogenesis in human sebocytes. Proc Natl Acad Sci U S A (2002) 1.22
Intradermal microneedle delivery of insulin lispro achieves faster insulin absorption and insulin action than subcutaneous injection. Diabetes Technol Ther (2011) 1.21
Accuracy in blood glucose measurement: what will a tightening of requirements yield? J Diabetes Sci Technol (2012) 1.20
Dose response of inhaled dry-powder insulin and dose equivalence to subcutaneous insulin lispro. Diabetes Care (2005) 1.19
IL6 gene promoter polymorphisms and type 2 diabetes: joint analysis of individual participants' data from 21 studies. Diabetes (2006) 1.18
Insulin and the CNS: effects on food intake, memory, and endocrine parameters and the role of intranasal insulin administration in humans. Physiol Behav (2004) 1.17
Continuous glucose monitoring: reliable measurements for up to 4 days with the SCGM1 system. Diabetes Technol Ther (2003) 1.16
Characterization of the influence of vildagliptin on model-assessed -cell function in patients with type 2 diabetes and mild hyperglycemia. J Clin Endocrinol Metab (2007) 1.16
Microneedle-based intradermal versus subcutaneous administration of regular human insulin or insulin lispro: pharmacokinetics and postprandial glycemic excursions in patients with type 1 diabetes. Diabetes Technol Ther (2011) 1.14
Time-action profile of inhaled insulin in comparison with subcutaneously injected insulin lispro and regular human insulin. Diabetes Care (2005) 1.10
IFN-alpha skews monocytes into CD56+-expressing dendritic cells with potent functional activities in vitro and in vivo. J Immunol (2008) 1.09
The SCGM1 System: subcutaneous continuous glucose monitoring based on microdialysis technique. Diabetes Technol Ther (2003) 1.09
Macrophage migration inhibitory factor (MIF) and risk for coronary heart disease: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Atherosclerosis (2008) 1.09
Impaired adrenal stress response in Toll-like receptor 2-deficient mice. Proc Natl Acad Sci U S A (2004) 1.09
Non-invasive glucose monitoring in patients with Type 1 diabetes: a Multisensor system combining sensors for dielectric and optical characterisation of skin. Biosens Bioelectron (2009) 1.08
Fat cells may be the obesity-hypertension link: human adipogenic factors stimulate aldosterone secretion from adrenocortical cells. Endocr Res (2004) 1.08
Biosimilar insulin and insulin antibodies. J Diabetes Sci Technol (2013) 1.08
Hypoglycemia warning signal and glucose sensors: requirements and concepts. Diabetes Technol Ther (2003) 1.08
Neuroendocrine neoplasms of the gastrointestinal tract. Dtsch Arztebl Int (2011) 1.05
The value of training in communication skills for continuing medical education. Patient Educ Couns (2010) 1.05
Chemokines and incident coronary heart disease: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Arterioscler Thromb Vasc Biol (2006) 1.04
Screening for undiagnosed diabetes in patients with acute myocardial infarction. Clin Res Cardiol (2008) 1.03
[The quality of CME questions as a component part of continuing medical education--an empirical study]. Z Arztl Fortbild Qualitatssich (2007) 1.02
Application of different methods for nuclear shape analysis with special reference to the differentiation of brain tumors. Anal Quant Cytol Histol (2006) 1.01
Altered disease course after initiation of self-monitoring of blood glucose in noninsulin-treated type 2 diabetes (ROSSO 3). J Diabetes Sci Technol (2007) 1.00
Dose-response relationship of insulin glulisine in subjects with type 1 diabetes. Diabetes Care (2007) 0.99
Oral insulin: a comparison with subcutaneous regular human insulin in patients with type 2 diabetes. Diabetes Care (2010) 0.99
Glucose sensors and the alternate site testing-like phenomenon: relationship between rapid blood glucose changes and glucose sensor signals. Diabetes Technol Ther (2003) 0.98
High prevalence of undiagnosed impaired glucose regulation and diabetes mellitus in patients scheduled for an elective coronary angiography. Clin Res Cardiol (2006) 0.97
Subclinical inflammation and diabetic polyneuropathy: MONICA/KORA Survey F3 (Augsburg, Germany). Diabetes Care (2009) 0.97
ROSSO-in-praxi follow-up: long-term effects of self-monitoring of blood glucose on weight, hemoglobin A1c, and quality of life in patients with type 2 diabetes mellitus. Diabetes Technol Ther (2011) 0.96
The "glucose pentagon": assessing glycemic control of patients with diabetes mellitus by a model integrating different parameters from glucose profiles. Diabetes Technol Ther (2009) 0.96
Systemic immune mediators and lifestyle changes in the prevention of type 2 diabetes: results from the Finnish Diabetes Prevention Study. Diabetes (2006) 0.96
Thyrotropin receptor autoantibodies in Graves' disease. Trends Endocrinol Metab (2005) 0.95
RANTES/CCL5 gene polymorphisms, serum concentrations, and incident type 2 diabetes: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Eur J Endocrinol (2008) 0.95
Corticotropin-releasing hormone system in human adipose tissue. J Clin Endocrinol Metab (2004) 0.94
Liver sinusoidal endothelial cells contribute to CD8 T cell tolerance toward circulating carcinoembryonic antigen in mice. Hepatology (2012) 0.93
Intra-individual variability of the metabolic effect of a novel rapid-acting insulin (VIAject) in comparison to regular human insulin. J Diabetes Sci Technol (2008) 0.93
[Efficacy and safety profile of a herbal drug containing nasturtium herb and horseradish root in acute sinusitis, acute bronchitis and acute urinary tract infection in comparison with other treatments in the daily practice/results of a prospective cohort study]. Arzneimittelforschung (2006) 0.92
Immune mediators in patients with acute diabetic foot syndrome. Diabetes Care (2009) 0.91
Comparison between Long-Menu and Open-Ended Questions in computerized medical assessments. A randomized controlled trial. BMC Med Educ (2006) 0.91
The role of a homoeopathic preparation compared with conventional therapy in the treatment of injuries: an observational cohort study. Complement Ther Med (2007) 0.91
Assessing the analytical performance of systems for self-monitoring of blood glucose: concepts of performance evaluation and definition of metrological key terms. J Diabetes Sci Technol (2013) 0.90
On what evidence-base do we recommend self-monitoring of blood glucose? Diabetes Res Clin Pract (2009) 0.90
Implementing disease management programs for type 2 diabetes in Germany. Manag Care (2006) 0.89
Morphology of tumor cell nuclei is significantly related with survival time of patients with glioblastomas. Clin Cancer Res (2005) 0.89
Wisconsin Card Sorting Test synchronizes the prefrontal, temporal and posterior association cortex in different frequency ranges and extensions. Hum Brain Mapp (2002) 0.89
ROSSO-in-praxi-international: long-term effects of self-monitoring of blood glucose on glucometabolic control in patients with type 2 diabetes mellitus not treated with insulin. Diabetes Technol Ther (2012) 0.89
Inflammation in metabolic syndrome and type 2 diabetes: Impact of dietary glucose. Ann N Y Acad Sci (2006) 0.89
Insulin assay standardization: leading to measures of insulin sensitivity and secretion for practical clinical care: response to Staten et al. Diabetes Care (2010) 0.89
Parameters affecting postprandial blood glucose: effects of blood glucose measurement errors. J Diabetes Sci Technol (2008) 0.88
Subcutaneous injection versus subcutaneous infusion of insulin: are the rates of absorption truly the same? J Diabetes Sci Technol (2011) 0.88
Acquired and inherited lipodystrophies. N Engl J Med (2004) 0.88
Adipocyte-secreted factors increase osteoblast proliferation and the OPG/RANKL ratio to influence osteoclast formation. Mol Cell Endocrinol (2011) 0.88
Nonlinear metabolic effect of insulin across the blood glucose range in patients with type 1 diabetes mellitus. J Diabetes Sci Technol (2010) 0.88
Exendin-4 upregulates the expression of Wnt-4, a novel regulator of pancreatic β-cell proliferation. Am J Physiol Endocrinol Metab (2011) 0.87
Serum selenium levels in patients with remission and relapse of graves' disease. Med Chem (2007) 0.87
[On-going investigations on efficacy and safety profile of a herbal drug containing nasturtium herb and horseradish root in acute sinusitis, acute bronchitis and acute urinary tract infection in children in comparison with other antibiotic treatments]. Arzneimittelforschung (2007) 0.87
Continuous glucose monitoring: evidence and consensus statement for clinical use. J Diabetes Sci Technol (2013) 0.87
Self-measurement of blood glucose in patients with type 2 diabetes: a health economic assessment. J Diabetes Sci Technol (2007) 0.86
Angiotensin blockade to reduce microvascular damage in diabetes mellitus. Dtsch Arztebl Int (2009) 0.86
Corticotropin-releasing hormone receptor expression on normal and tumorous human adrenocortical cells. Neuroendocrinology (2006) 0.86
IL-10 induces gene expression in macrophages: partial overlap with IL-5 but not with IL-4 induced genes. Cytokine (2003) 0.86
Evidence of a combined cytotoxic thyroglobulin and thyroperoxidase epitope-specific cellular immunity in Hashimoto's thyroiditis. J Clin Endocrinol Metab (2012) 0.85
[Novel aspects in the mechanisms of steroid diabetes and the regulation of hepatic glucose production by insulin and steroids]. Med Klin (Munich) (2003) 0.85
Sfrp5 correlates with insulin resistance and oxidative stress. Eur J Clin Invest (2013) 0.84
A case of catecholamine and glucocorticoid excess syndrome due to a corticotropin-secreting paraganglioma. Ann N Y Acad Sci (2006) 0.84